Search

everythinglearnresearchcommunity

for

Search:↓

Magnesium supplements improved quality of life for women with polycystic ovary syndrome, but didn't help with acne, hair loss, or abnormal bleeding.

Losing weight and eating better are key to managing metabolic syndrome and its related conditions.

Alopecia areata is a reversible, autoimmune-related hair loss that can have significant emotional impact and uncertain treatment effectiveness.

SCD1 inhibitors can cause skin issues in rodents.

Eating a balanced diet with specific nutrients can help manage menopause symptoms and prevent related health issues.

Losing 5-10% body weight can improve PCOS symptoms, letrozole is better than clomiphene for fertility, and managing weight and blood sugar is important to reduce pregnancy complications.

Oxidative stress, not insulin resistance, is significantly related to free androgen index in PCOS.

Puerariae Lobatae Radix can reduce sebaceous gland size and secretion, potentially treating related skin conditions.

PCOS is linked to diabetes and insulin resistance, and managing AGEs may help treat related symptoms.

African American women have a higher risk of preterm delivery than Caucasian women, and inflammatory stimuli affect gene expression in cells related to PCOS, showing a heightened inflammatory state in women with PCOS.

Severe insulin resistance can be managed with medication, lifestyle changes, and treatment for related conditions.

A personalized nutrition plan improved hair and skin health in a young man.

Poor nutrition, higher BMI, and stress may worsen seborrheic dermatitis.

The new rodent model successfully mimics non-lean human PCOS symptoms.

The diagnosis of polycystic ovary syndrome (PCOS) requires a detailed patient history, ultrasound scanning, hormone level checks, and assessments of ovulation, obesity, and insulin resistance. It's a variable condition that needs individualized management and is a significant risk factor for type 2 diabetes.

Eating a high inositol diet significantly improves insulin resistance and hormone levels in women with PCOS.

Preventive measures and effective management are crucial for reducing skin side effects in cancer treatment.

Ellagic acid can help treat skin issues, but its effectiveness is limited by poor absorption, so new delivery methods are being explored.

Bee venom shows promise for treating cancer, infections, inflammation, and hair loss.

A balanced diet with proteins, vitamins, and minerals is crucial for managing skin disorders.

Colchicine might help treat different skin diseases, but more research is needed to confirm its effectiveness and safe dosage.

Mitochondrial dysfunction links metabolic syndrome and inflammatory skin diseases, suggesting targeted therapies and lifestyle changes.

Belly fat is the main predictor of nonalcoholic fatty liver disease in both women with Polycystic ovary syndrome and healthy women.

Nanocarriers show promise for improving skin drug delivery in treating skin conditions.

Succinic acid helps improve skin conditions like acne and rosacea.

The black orchid Brasiliorchis schunkeana produces chemicals that attract certain insects and have potential antimicrobial properties.

Lifestyle changes during the early COVID-19 outbreak led to more cases of acne and other skin conditions, but fewer cases of rosacea and skin infections.

Polycystic Ovary Syndrome (PCOS) affects 6%-15% of women of reproductive age, causing symptoms like acne and hair loss, and increasing the risk of type 2 diabetes and heart disease; it's managed through diet, exercise, and medications like Metformin and hormonal contraceptives.

PCOS is complex, affects many, and requires informed management and lifestyle changes.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.